发明名称 |
PROSTAGLANDIN REDUCTASE |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide a polypeptide effective for controlling lipid and glucose metabolism by controlling PPAR (peroxisome proliferator activated receptor) activity and a medicinal composition containing the polypeptide. <P>SOLUTION: The present invention provides an isolated polypeptide not reducing leukotriene B4, but reducing 15-ketoprostaglandin and having a specific sequence or its functional equivalent and a double stranded ribonucleic acid (dsRNA) for inhibiting expression of 15-ketoprostaglandin-▵13-reductase. <P>COPYRIGHT: (C)2006,JPO&NCIPI |
申请公布号 |
JP2005348733(A) |
申请公布日期 |
2005.12.22 |
申请号 |
JP20050170722 |
申请日期 |
2005.06.10 |
申请人 |
NATIONAL TAIWAN UNIV |
发明人 |
CHUANG LEE-MING;CHANG ZEE-FEN;CHOU WEN-LING |
分类号 |
A61K45/00;A61K31/12;A61K31/352;A61K31/353;A61K31/37;A61K31/7105;A61P1/04;A61P1/18;A61P3/04;A61P3/06;A61P3/10;A61P5/28;A61P9/10;A61P9/12;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P19/10;A61P25/00;A61P25/28;A61P27/02;A61P29/00;A61P35/00;A61P43/00;C07K16/40;C12N9/02;C12N9/04;C12N15/09;C12P21/08 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|